Role of clinical biomarkers in predicting the effectiveness of omalizumab

OBJECTIVE: To explore whether baseline clinical biomarkers and characteristics can be used to predict the responsiveness of omalizumab. METHODS: We retrospectively analyzed a cohort of patients with severe asthma who received omalizumab treatment and collected their baseline data and relevant labora...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Li, Chunxiao, Wan, Jingxuan, Zhang, Mengyuan, Nong, Ying, Lin, Jiangtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164849/
https://www.ncbi.nlm.nih.gov/pubmed/37148201
http://dx.doi.org/10.1177/17534666231170821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164849/
https://www.ncbi.nlm.nih.gov/pubmed/37148201
http://dx.doi.org/10.1177/17534666231170821

Ejemplares similares